The Role of the Transforming Growth Factor-β Signaling Pathway in Gastrointestinal Cancers
Tasuku Matsuoka(Osaka Metropolitan University), Masakazu Yashiro(Osaka Metropolitan University)
Cited by 20
Related Papers
Biomarkers of gastric cancer: Current topics and future perspective
|World Journal of Gastroenterology|2018|503
A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma
|British Journal of Cancer|2013|58
PI3K/Akt signalling is required for the attachment and spreading, and growth in vivo of metastatic scirrhous gastric carcinoma
|British Journal of Cancer|2012|56
Synergistic antitumor effects of FGFR2 inhibitor with 5‐fluorouracil on scirrhous gastric carcinoma
|International Journal of Cancer|2009|51